Board of Directors

Dr. Marisa Nucci is an Associate Professor in the Division of Women’s and Perinatal Pathology in the Department of Pathology at the Brigham and Women’s Hospital in Boston, MA, USA. She also serves as a Consultant Pathologist for the Dana Farber/Harvard Cancer Center where she is an Associate Member of the Gynecologic Cancer and Sarcoma Programs.

Dr. Nucci was born in Newark, NJ. She did her undergraduate training at Haverford College and medical training at the Johns Hopkins University School of Medicine in Baltimore, MD, and completed an AP residency as well as the Women’s and Perinatal Pathology Fellowship at the Brigham and Women’s Hospital. She has been on staff at the Brigham and Women's Hospital since 1996.

She is past president of the New England Society of Pathologists and serves on the editorial boards of The International Journal of Gynecologic Pathology, Human Pathology, and Advances in Anatomic Pathology. She is a member of the Education Committee of the United States and Canadian Academy of Pathology (2011-2017) and serves as Chair of the Subcommittee for Unique Live Course Offerings (2012-2017). She has co-directed five short courses at the USCAP (1999-2009; 2011-2014) and the Long Course on Practical Topics in Uterine Pathology (2015). She has also served on the abstract review board for the USCAP (2000-2007). She is also the Chair of the Membership Committee for the Arthur Purdy Stout Society and is a member of the Surgical Pathology Committee of the College of American Pathology. She is the co-editor of three widely read major gynecologic pathology textbooks: Diagnostic Gynecologic and Obstetric Pathology edited by Drs. Crum, Nucci and Lee; Gynecologic Pathology: A Volume in the Series Foundations in Diagnostic Pathology edited by Drs. Nucci and Oliva; and Diagnostic Pathology Gynecological edited by Drs. Nucci and Oliva.

Dr. Laura Collins is the Vice Chair of Anatomic Pathology and Director of Breast Pathology at Beth Israel Deaconess Medical Center (BIDMC), and Professor of Pathology at Harvard Medical School in Boston. She has previously served as the Program Director of both the Residency and Selective Pathology Fellowship Training Programs at BIDMC. Dr. Collins earned her medical degree from the Charing Cross and Westminster Medical School in London, UK. She completed a residency in Anatomic and Clinical Pathology and Cytology Fellowship at BIDMC. Dr. Collins' research, teaching and clinical activities are focused on diseases of the breast. She is a member of the USCAP Board of Directors and is the coordinator of interactive microscopy courses in breast pathology at the USCAP Interactive Center in Palm Springs, California. She is also the current President of the Arthur Purdy Stout Society of Surgical Pathologists.

Dr. Billings completed his pathology residency at Indiana University School of Medicine in Indianapolis.  Following residency he completed a fellowship in soft tissue pathology with Dr. Sharon Weiss at Emory University and a dermatopathology fellowship with Dr. Antoinette Hood at Indiana University.  Upon completion of his post-graduate studies, he joined the faculty at Indiana University School of Medicine, where he practiced for several years. In 2007 he joined the faculty at the Cleveland Clinic where he serves as a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine and as co-director of the dermatopathology section.  He also staffs the soft tissue pathology service.

His research interests are in dermatopathology and soft tissue pathology, with a special emphasis on cutaneous soft tissue tumors.  He has authored over 100 articles, numerous book chapters as well as a book on inflammatory diseases of the skin.  He is on the editorial board of several journals and a peer reviewer for many more.  He has a strong interest in education and gives numerous invited lectures and CME courses.  He inaugurated interactive microscopy for USCAP.

Adeboye O. Osunkoya, MD is a Professor of Pathology and Urology at Emory University School of Medicine, where he directs the Urologic Pathology service and the Surgical Pathology Fellowship Program. He serves in leadership roles in national and international organizations and is currently an elected member of the Board of Directors of the United States and Canadian Academy of Pathology (USCAP), Member-at-Large, Board of Trustees of the Arthur Purdy Stout Society, Chair of the Prize and Award Committee, Arthur Purdy Stout Society of Surgical Pathologists, and Director of Urologic Pathology at the USCAP Interactive Center. He previously served as Chair of the Excellence in Urological Pathology Resident/Fellow Research Award Committee of the International Society of Urological Pathology (2013-2018), Chair of the Stephen Vogel Award Committee of the USCAP (2014-2016), member of the Education Committee of the USCAP (2012-2016), USCAP Ambassador, member of the Stowell-Orbison Award Committee of the USCAP and Abstract Review Committee of the USCAP. He serves on the Editorial Board of several well-known Journals. Dr. Osunkoya has presented several lectures and conferences in the United States and abroad, including USCAP, European Congress of Pathology, International Academy of Pathology, and Asia Pacific International Academy of Pathology meetings. In addition, he was the Director of the Diagnostic Challenges in Prostate Pathology USCAP Short Course (2015-2017) and Director of the Interactive Microscopy Courses on Prostate Pathology in 2015 (Boston and Saint Louis), 2016 (Seattle and Palm Springs), 2017 (San Antonio and Palm Springs), and 2018 (Palm Springs). He was an invited speaker at the 2017 USCAP Long Course and 2017 Practical Pathology Seminars. Dr. Osunkoya has been involved in several major research grants over the years, and has published over 140 manuscripts, over 20 book chapters, and has won numerous awards including the very prestigious Benjamin Castleman Award (2010) and the highly coveted Arthur Purdy Stout Prize (2015).

On a personal note, Dr. Osunkoya is very happily married to his Medical School sweetheart Ojoru Osunkoya, MD (Pediatrician) and they are blessed with two children, Siji (Son) and Seyi (Daughter). He considers them to be his greatest achievement in life.

Dr. Ralph Hruban attended the Johns Hopkins University School of Medicine. He did a residency in Anatomic Pathology at Hopkins, followed by a fellowship in Surgical Pathology at Memorial Sloan Kettering Cancer Center in New York. Dr. Hruban then returned to Hopkins where he rose through the ranks. He is now the Baxley Professor and Director of the Department of Pathology, and the Director of the Sol Goldman Pancreatic Cancer Research Center.

Dr. Hruban has devoted his academic career to the study of tumors of the pancreas. He has made significant contributions to our understanding of the genetic drivers of all types of pancreas tumors - ductal, acinar, cystic and neuroendocrine- and he helped translate these genetic discoveries to patient care. His work on Pancreatic Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMNs), the precursor lesions that give rise to invasive pancreas cancer, has led to new approaches to the early detection of pancreatic neoplasia. He founded the National Familial Pancreas Tumor Registry (NFPTR), and helped define the clustering of pancreatic cancer in families as well as discover new familial pancreatic cancer genes (PALB2 and ATM). These discoveries now guide genetic counseling. Dr. Hruban has over 750 scientific papers, and authored or coauthored six books, including the ARP Fascicle on Tumors of the Pancreas and the World Health Organization's "blue book" on tumors of the digestive tract. Ralph is cited by the "Essential Science Indicators" as the most cited pancreas cancer scientist in the world, and has been recognized on multiple occassions as a Thomson Reuters Highly Cited Researcher. He was inducted into the German National Academy of Sciences Leopoldina. Selected awards include the Ramzi Cotran Award from the United States and Canadian Academy of Pathology; the Arthur Purdy Stout Prize from the Arthur Purdy Stout Society; the Fred Stewart Award; the Frank H. Netter Award for Special Contributions to Medical Education; the Ruth Leff Siegel Award for Excellence in Pancreatic Cancer Research; the Johns Hopkins University Distinguished Alumni Award; and five teaching awards from the School of Medicine, including the Educational Innovation Award. He received the Team Science Award from the American Association for Cancer Research in 2013 and in 2017. He was appointed to the Board of Directors of the United States and Canadian Academy of Pathology in 2017.

Dr. Magi-Galluzzi is the Division Director of Anatomic Pathology and Professor of Pathology at the University of Alabama at Birmingham. She received her MD at the University of Ancona, School of Medicine, Italy and her PhD in Oncologic Human Pathology at the University of Verona, Italy. She completed her residency in Anatomic and Clinical Pathology at Rush University Medical Center in Chicago (1997-1999) and Brigham & Women’s Hospital, Harvard Medical School in Boston (1999-2001), followed by a fellowship in Urologic Pathology at the Johns Hopkins University in Baltimore (2001-2003). She was on staff at the Cleveland Clinic from 2003 to 2018 and Director of Genitourinary pathology from 2004 to 2018.

Her clinical expertise is the pathological diagnosis of genitourinary diseases, including prostate, bladder, testicular, adrenal and kidney malignancies. Her research interest focuses on prostate carcinogenesis and in the discovery and validation of tumor markers and genomic tests of value in furthering the goals of successful treatment and understanding of the pathogenesis of genitourinary disease. She is the author of numerous (~200) peer-reviewed publications, invited reviews and book chapters, as well as the editor of two books on genitourinary pathology. She has presented and lectured extensively at national and international meetings and has conducted national and international courses, workshops and slide seminars in urological pathology.

Dr. Magi-Galluzzi is a member of the USCAP Board of Directors and a board member-at-large of the Arthur Purdy Stout Society (APSS).

Dr. Lim is the Director of the Joint Division of Hematopathology, Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia in the Department of Pathology and Laboratory Medicine, Director of the Hematopathology Fellowship Program, Interim Director of the Clinical Flow Cytometry Laboratory, and the Director of the Lymphoma Biology Program at the Abramson Cancer Center.

Dr. Lim received an M.D. from the University of Calgary and a Ph.D. in Molecular Oncology from the University of Calgary and National Cancer Institute Lab of Pathology jointly. Dr. Lim obtained her Hematopathology fellowship training at the National Cancer Institute after which she assumed a faculty position at the University of Toronto (1998-2000), the University of Utah (2000-2006), and the University of Michigan (2000-2015) before moving to the University of Pennsylvania in 2015. She has held numerous leadership positions and served on training and education committees for the Association for Molecular Pathology and the United States and Canadian Academy of Pathology. She is the Vice-Chair of the Non-Hodgkin Lymphoma Disease Committee of the Children’s Oncology Group and participates in integrated translational research in pediatric lymphoma. Her research interests are focused on elucidating mechanisms involved in lymphoma pathogenesis. She has participated and directed numerous CME activities for AMP, ASCP, CAP, and USCAP.

Dr. Perry is a Professor at the University of California in San Francisco, where he serves as the Director of the Neuropathology Division and the Neuropathology Fellowship program. He received his MD and residency training at UT Southwestern Medical Center in Dallas, Texas, followed by fellowships in surgical pathology, neuropathology, and molecular cytogenetics research at the Mayo Clinic in Rochester, MN. His interests have focused mostly on classification, grading, and molecular characterization of both adult and pediatric brain tumors. He has authored over 430 publications and participated as a senior advisor/editor for the WHO 2016 brain tumor classification scheme. He has also served as a chief editor for Brain Pathology (official journal for the International Society of Neuropathology), the 2010 Practical Surgical Neuropathology textbook (second edition now in press), and the 2015 9th edition of Greenfield’s Neuropathology. USCAP has been his professional home since 1992, where he has previously enjoyed many roles, including abstract reviewer, session moderator, companion society speaker, evening session panelist and moderator, short course faculty, molecular special course faculty, and publications committee member.

Dr. Perry also maintains an active surgical neuropathology consult service and is a frequently invited lecturer. Furthermore, he particularly adores the creative side of Pathology, making use of his longstanding passions for both music and teaching. In this respect, he has been featured in several media stories for using "neuropathology songs" in education, including a CD recording of 16 medical ballads and a YouTube male a cappella rendition of ‘Brain Tumor Rhapsody’ set to Bohemian Rhapsody.